The Etiology of Community‐Acquired Pneumonia in Australia: Why Penicillin plus Doxycycline or a Macrolide Is the Most Appropriate Therapy
- 15 May 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (10), 1513-1521
- https://doi.org/10.1086/586749
Abstract
Background. Available data on the etiology of community-acquired pneumonia (CAP) in Australia are very limited. Local treatment guidelines promote the use of combination therapy with agents such as penicillin or amoxycillin combined with either doxycycline or a macrolide.Keywords
This publication has 39 references indexed in Scilit:
- Severe community‐acquired pneumonia: an Australian perspectiveInternal Medicine Journal, 2005
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Improved Diagnosis of the Etiology of Community-Acquired Pneumonia with Real-Time Polymerase Chain ReactionClinical Infectious Diseases, 2005
- Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factorsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Quinolone Resistance among Pneumococci: Therapeutic and Diagnostic ImplicationsClinical Infectious Diseases, 2004
- The Continuing Challenge of Lower Respiratory Tract InfectionsClinical Infectious Diseases, 2004
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- Community-Acquired PneumoniaThe New England Journal of Medicine, 1995
- Aldosterone and its mechanism of action: more questions than answersAustralian and New Zealand Journal of Medicine, 1995
- Etiology of community-acquired pneumonia in patients requiring hospitalizationEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985